Old Web
English
Sign In
Acemap
>
Paper
>
CM227/CM9-LA: evidence supporting ipilimumab-based immunotherapy in the first-line treatment of metastatic NSCLC
CM227/CM9-LA: evidence supporting ipilimumab-based immunotherapy in the first-line treatment of metastatic NSCLC
2020
Emily F. Collier
Sarah B. Goldberg
Keywords:
first line treatment
Immunotherapy
Oncology
Internal medicine
Medicine
Ipilimumab
Correction
Source
Cite
Save
Machine Reading By IdeaReader
15
References
0
Citations
NaN
KQI
[]